The FDA has approved a new drug combination to treat two rare disorders that cause blood vessels to become inflamed. 

The FDA has a approved a new drug to treat systemic juvenile idiopathic arthritis - a rare type of arthritis but the most common form affecting children.

The U.S. Food and Drug Administration (FDA) has approved the cPAX Aneurysm Treatment System for surgery on brain aneurysms that are difficult to manage because of their size and shape.

The FDA has approved a test that detects an infection that causes diarrhea, other intestinal problems and sometimes death.

The FDA continues to receive reports about a life-threatening side effect of a dental pain reliever called benzocaine .

The U.S. Food and Drug Administration approved a new device that provides neurointerventional surgeons with another tool to treat brain aneurysms without performing open surgery.

On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets ( gabapentin enacarbil ), a once-daily treatment for moderate-to-severe restless legs syndrome ( RLS ).

The U.S. Food and Drug Administration (FDA) today approved vandetanib to treat adult patients with late-stage (metastatic) medullary thyroid cancer who are ineligible for surgery and who have disease that is growing or causing symptoms.

On March 25, 2011, FDA approved VIRAMUNE XR ( nevirapine ), a 400 mg extended release tablet formulation. VIRAMUNE XR is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.

The FDA is warning consumers to stop using Soladek , a vitamin-solution product, because the product may contain dangerously high levels of vitamins A and D.